Market revenue in 2023 | USD 71.2 million |
Market revenue in 2030 | USD 173.4 million |
Growth rate | 13.6% (CAGR from 2023 to 2030) |
Largest segment | Regenerative medicine |
Fastest growing segment | Drug Discovery & Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regenerative Medicine, Drug Discovery & Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.45% in 2023. Horizon Databook has segmented the Japan human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of technological advancements pertaining to stem cell research in the country coupled with well-defined regulatory policies for research on human embryonic stem cells in the country is supportive for the estimated large share of the country.
In January 2017, Japanese research team reported that they have successfully created miniature bowels from hESCs. These bowels make movements similar to those of natural intestines and are capable of peristalsis to aid movement of food and body waste through the digestive tract.
In addition to this, in February 2015, a team of Japanese researchers successfully developed retinal tissue using hESCs. This is expected to help to understand the mechanism of retinal working and also aid treatment of eye disorders.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Japan human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account